Capital raised by NextPoint Therapeutics
1 Form D filing · first filed Jul 2026 · Cambridge, MA
Secretary & Treasurer
Signatory on NextPoint Therapeutics's Form D filings · $33.7M raised across 1
Jeffrey Lacey is on file as Secretary & Treasurer at NextPoint Therapeutics in Cambridge, MA. NextPoint Therapeutics has 1 Form D filing on record, $33.7M raised in total. Jeffrey Lacey appears as a signatory on the company's filings.
No other people are on file at NextPoint Therapeutics. Form D filings only name the signatory and the company's executive officers.
A tri-functional B7-H7-directed checkpoint inhibitor in Phase 1 clinical trials that blocks the B7-H7/KIR3DL3 interaction, enhances TMIGD2 co-stimulation, and drives antibody-dependent cellular cytotoxicity.
